MEDVi, a telehealth platform serving more than 100,000 patients, today announced an expanded physician-led program ...

Please provide your email address to receive an email when new articles are posted on . A multidisciplinary comprehensive obesity care model increased GLP-1 persistence at 1 year. Patients in the ...

“The GLP-1 landscape is expected to broaden significantly,” said Dr. Christopher McGowan, a gastroenterologist who runs a weight loss clinic in Cary, North Carolina. “For the first time, medical ...

GLP-1 drugs don’t just change what people eat,” Karthik Srinivasan, communications strategy consultant, tells Invezz. They change whether people want to eat at all. That’s why this stops being a ...

Eli Lilly working Humana to distribute obesity medications through employer-focused programs via CenterWell Pharmacy.

In recent days, Amazon Pharmacy announced it would begin offering Novo Nordisk’s Wegovy once-daily weight-loss pill through ...

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including Wegovy and Zepbound are expected to be easier to access and afford. And new ...

A key to the pill's success will be attracting cash-paying consumers who cannot obtain insurance coverage, a stark shift from the dominant business model.